Chronic lymphocytic leukemia appears to progress faster in black patients and to result in shorter survival times compared with white patients despite the administration of similar treatments. The study of 84 black patients and more than 1,500 nonblack patients took into account factors related to cancer severity and the timing of treatment. Researchers believe that, based on their results, biological factors may be involved in disparate outcomes. The study was reported in the journal Cancer.
Black CLL patients have shorter survival time despite equal treatment
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||